Literature DB >> 29143161

Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study.

Caroline Morbach1, Thomas Buck2,3, Christian Rost4,5, Sebastian Peter4,6, Stephan Günther4,7, Stefan Störk1, Christiane Prettin8, Raimund Erbel2, Georg Ertl1, Christiane E Angermann9.   

Abstract

BACKGROUND: Patients with suspected heart failure (HF) often present first to general practitioners (GPs). Timely and accurate HF diagnosis and reliable prognostic information have remained unmet goals in primary care, where patient evaluation often relies on clinical assessment only. The Handheld-BNP program investigates whether additional use of portable echocardiography (ECHO) and point-of-care determination of B-type natriuretic peptide (BNP) improves the accuracy of HF diagnosis and aids risk prediction in primary care. METHODS AND
RESULTS: A research network was established between 2 academic centers, 2 × 6 cardiologists, and 2 × 24 GPs inexperienced with ECHO and BNP. The Training Study investigates the feasibility of implementing GP use and interpretation of ECHO and BNP. After training, competence is assessed using multiple-choice testing (pass mark: > 80% correct diagnoses). In the cluster-randomized four-arm Screening Study, each GP passes in random order through four study arms: clinical assessment (CA), CA + BNP, CA + ECHO, and CA + ECHO + BNP. Cardiologists' diagnoses serve as reference. Primary endpoint is the rate of correct GP diagnoses per study arm. In the Prognostic Follow-Up Study, patients are followed up centrally for 72 months. Forty-four GPs were successfully trained. With 225 ± 34 (75 ± 3) and 233 ± 28 (81 ± 7) min, respectively, total ECHO (BNP) training times were similar between centers I and II. Furthermore, training results did not differ between centers.
CONCLUSIONS: Standardized training of limited duration enabled GPs to use ECHO and BNP for HF diagnosis. The Handheld-BNP program will provide robust evaluation of the diagnostic effectiveness and prognostic value of these tools in primary care. TRIAL REGISTRATION: http://www.controlled-trials.com (ISRCTN23325295).

Entities:  

Keywords:  B-type natriuretic peptide; Diagnosis; Heart failure; Portable echocardiography; Primary care; Prognosis

Mesh:

Substances:

Year:  2017        PMID: 29143161     DOI: 10.1007/s00392-017-1181-3

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  73 in total

1.  Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study.

Authors:  Ahmet Fuat; A Pali S Hungin; Jeremy James Murphy
Journal:  BMJ       Date:  2003-01-25

Review 2.  Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.

Authors:  Chaitanya Madamanchi; Hassan Alhosaini; Arihiro Sumida; Marschall S Runge
Journal:  Int J Cardiol       Date:  2014-08-09       Impact factor: 4.164

3.  Physician-performed point-of-care echocardiography using a laptop platform compared with physical examination in the cardiovascular patient.

Authors:  K T Spencer; A S Anderson; A Bhargava; A C Bales; M Sorrentino; K Furlong; R M Lang
Journal:  J Am Coll Cardiol       Date:  2001-06-15       Impact factor: 24.094

4.  The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study.

Authors:  Alex Zaphiriou; Stephen Robb; Tarita Murray-Thomas; Gustavo Mendez; Kevin Fox; Theresa McDonagh; Suzanna M C Hardman; Henry J Dargie; Martin R Cowie
Journal:  Eur J Heart Fail       Date:  2005-06       Impact factor: 15.534

5.  Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease.

Authors:  Frans H Rutten; Maarten-Jan M Cramer; Diederick E Grobbee; Alfred P E Sachs; Johannes H Kirkels; Jan-Willem J Lammers; Arno W Hoes
Journal:  Eur Heart J       Date:  2005-04-28       Impact factor: 29.983

6.  B-type natriuretic peptide in the evaluation and management of dyspnoea in primary care.

Authors:  E Burri; K Hochholzer; N Arenja; H Martin-Braschler; L Kaestner; H Gekeler; T Hatziisaak; M Büttiker; A Fräulin; M Potocki; T Breidthardt; T Reichlin; T Socrates; R Twerenbold; C Mueller
Journal:  J Intern Med       Date:  2012-06-12       Impact factor: 8.989

7.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.

Authors:  M R Cowie; A D Struthers; D A Wood; A J Coats; S G Thompson; P A Poole-Wilson; G C Sutton
Journal:  Lancet       Date:  1997-11-08       Impact factor: 79.321

8.  Echocardiography in chronic heart failure in the community.

Authors:  N M Wheeldon; T M MacDonald; C J Flucker; A D McKendrick; D G McDevitt; A D Struthers
Journal:  Q J Med       Date:  1993-01

9.  Assessment of Primary Care Physicians' Use of a Pocket Ultrasound Device to Measure Left Ventricular Mass in Patients with Hypertension.

Authors:  Paul Bornemann; Jeremy Johnson; Samuel Tiglao; Amina Moghul; Sheila Swain; Gina Bornemann; Mike Lustik
Journal:  J Am Board Fam Med       Date:  2015 Nov-Dec       Impact factor: 2.657

10.  Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy study.

Authors:  Clare J Taylor; Andrea K Roalfe; Rachel Iles; Fd Richard Hobbs; P Barton; J Deeks; D McCahon; M R Cowie; G Sutton; R C Davis; J Mant; T McDonagh; L Tait
Journal:  Br J Gen Pract       Date:  2016-12-05       Impact factor: 5.386

View more
  2 in total

1.  Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion.

Authors:  Anna Bauer; Markus Khalil; Monika Lüdemann; Jürgen Bauer; Anoosh Esmaeili; Roberta De-Rosa; Norbert F Voelkel; Hakan Akintuerk; Dietmar Schranz
Journal:  Clin Res Cardiol       Date:  2018-04-16       Impact factor: 5.460

Review 2.  Molecular Mechanism of Induction of Bone Growth by the C-Type Natriuretic Peptide.

Authors:  Estera Rintz; Grzegorz Węgrzyn; Toshihito Fujii; Shunji Tomatsu
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.